Literature DB >> 2873780

Taxol: mechanisms of action and resistance.

S B Horwitz, L Lothstein, J J Manfredi, W Mellado, J Parness, S N Roy, P B Schiff, L Sorbara, R Zeheb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2873780     DOI： 10.1111/j.1749-6632.1986.tb38455.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  35 in total

Review 1.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

Review 2.  New cytotoxic drugs and targets in oncology.

Authors:  J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

3.  A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.

Authors:  J Gao; O Murase; R L Schowen; J Aubé; R T Borchardt
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

4.  Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.

Authors:  Jingwei Xie; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2005-09-03       Impact factor: 4.200

5.  Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.

Authors:  M Orth; K Unger; U Schoetz; C Belka; K Lauber
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

Review 6.  1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

Authors:  Killian Oukoloff; Bobby Lucero; Karol R Francisco; Kurt R Brunden; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

Review 7.  [Current developments in use of docetaxel (taxotere) in gynecologic oncology].

Authors:  C Jackisch
Journal:  Med Klin (Munich)       Date:  1998-09-15

8.  Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

Authors:  L R Kelland; G Abel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Human liver microsomal metabolism of paclitaxel and drug interactions.

Authors:  P B Desai; J Z Duan; Y W Zhu; S Kouzi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

10.  Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.

Authors:  T C Chou; G M Otter; F M Sirotnak
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.